ARTL
ARTL
NASDAQ · Pharmaceuticals

Artelo Biosciences Inc

$1.26
+0.03 (+2.44%)
As of Jun 23, 10:22 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,146.0% upside
Low Target $11.87
Average Target $15.70
High Target $22.80
Current Price $1.26
Current
$1.26
Target
$15.70
$11.87 $15.70 avg $22.80
Scenario Analysis
Bear Case
$11.87
842.1%
Low target
Base Case
$15.70
+1,146.0%
Avg target
Bull Case
$22.80
+1,709.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$85.80
-98.5% from high
52-Week Low
$1.19
+5.9% from low
Target vs 52W High
$15.70
-81.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%